BSE filing, NSE: SUDARSCHEM. Summary written from the filing by ALFA Finder's alert engine.
Sudarshan Chemical Industries Ltd: key numbers
- Share price
- ₹1,064.40
- Market cap
- ₹8,474 Cr
- Revenue (annual)
- ₹9,787 Cr
- Net profit (annual)
- ₹22.30 Cr
- P/E (TTM)
- 117.0×Sector 34.1×
- Promoter holding
- 9.32%+1.13% QoQ
- FII holding
- 8.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sudarshan Chemical Industries Ltd
All →Sudarshan Chemical Industries Employee Stock Options
Sudarshan Chemical allotted 19,350 equity shares to employees exercising options under its 2018 ESOP plan. The allotment is at an exercise price of Rs 349.35 per share.
Sudarshan Chemical Industries Credit Rating
India Ratings has revised the outlook on Sudarshan Chemical Industries' debt facilities to Positive from Stable, while affirming the existing credit ratings.
Sudarshan Chemical Industries Other Announcement
Sudarshan Chemical Industries submitted its quarterly shareholding pattern for the period ending 30 September 2026, consistent with regulatory filing requirements under Regulation 31.
Sudarshan Chemical Industries Legal & Regulatory
Sudarshan Chemical Industries announced that Maharashtra State GST officials have initiated an inspection and search proceeding at some of its offices and manufacturing units.
Sudarshan Chemical Industries Acquisition Worth ₹150.8 Cr
Sudarshan Chemical executed a share purchase agreement to acquire a 15.89% stake in Sudarshan Colorants India Limited for ₹150.76 Crore.
- Value
- ₹150.8 Cr
Sudarshan Chemical Industries Management Change
Sudarshan Chemical Industries Limited has appointed Mr. Amit Deshpande as the company's General Counsel, effective September 21, 2026.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.